UBXN11

Across TCGA pan-cancer cohorts, UBXN11 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated UBXN11 data layer compared with 29 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher UBXN11 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated UBXN11 expression acts as an unfavorable survival marker.

PDAC and LSCC are the cancer types where UBXN11 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Median	All	0.586	0.919	.007	12	view →
LSCC	OS	Median	II,III,IV	0.865	1.000	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

UBXN11–PDAC (OS)

Open the PDAC breakdown →